Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice.

BACKGROUND: Alloimmunization can be a significant barrier to red blood cell (RBC) transfusion. While alloantigen matching protocols hold promise in reducing alloantibody formation, transfusion-dependent patients can still experience RBC alloimmunization and associated complications even when matching protocols are employed. As a result, complementary strategies capable of actively preventing alloantibody formation following alloantigen exposure are warranted. STUDY DESIGN AND METHODS: We examined whether pharmacological removal of macrophages using clodronate may provide an additional strategy to actively inhibit RBC alloimmunization using two preclinical models of RBC alloimmunization. To accomplish this, mice were treated with clodronate, followed by transfusion of RBCs expressing the HOD (HEL, OVA, and Duffy) or KEL antigens. On days 5 and 14 post transfusion, anti-HOD or anti-KEL IgM and IgG antibodies were evaluated. RESULTS: Low dose clodronate effectively eliminated key marginal zone macrophage populations from the marginal sinus. Prior treatment with clodronate, but not empty liposomes, also significantly inhibited IgM and IgG anti-HOD alloantibody formation following transfusion of HOD RBCs. Similar exposure to clodronate inhibited IgM and IgG antibody formation following KEL RBC transfusion. CONCLUSIONS: Clodronate can inhibit anti-HOD and anti-KEL antibody formation following RBC transfusion in preclinical models. These results suggest that clodronate may provide an alternative approach to actively inhibit or prevent the development of alloantibodies following RBC transfusion, although future studies will certainly be needed to fully explore this possibility.

Systematic control of experimental inconsistency in combinatorial materials science.

We developed a method to systematically control experimental inconsistency, which is one of the most troublesome and difficult problems in high-throughput combinatorial experiments. The topic of experimental inconsistency is never addressed, even though all scientists in the field of combinatorial materials science face this very serious problem. Experimental inconsistency and material property were selected as dual objective functions that were simultaneously optimized. Specifically, in an attempt to search for promising phosphors with high reproducibility, photoluminescence (PL) intensity was maximized, and experimental inconsistency was minimized by employing a multiobjective evolutionary optimization-assisted combinatorial materials search (MOEO combinatorial material search) strategy. A tetravalent manganese-doped alkali earth germanium/titanium oxide system was used as a model system to be screened using MOEO combinatorial materials search. As a result of MOEO reiteration, we identified a halide-detached deep red phosphor with improved PL intensity and reliable reproducibility.

Search for new red phosphors using genetic algorithm-assisted combinatorial chemistry.

A genetic algorithm was employed in association with high-throughput synthesis and characterization in an attempt to search for red phosphors with high photoluminescent intensity. A tetravalent manganese-doped alkali earth germanium oxide system, with an emission color close to a desirable deep red, was screened with the assistance of a genetic algorithm to pinpoint the phosphor exhibiting the highest photoluminescence. As the genetic algorithm was in progress, the PL intensity increased and maximized in the fourth generation. The highest and the average PL intensity of the fourth generation improved by 23 and 120%, respectively, compared with that of the first generation.